Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Aging and Disease|August 12, 2014
Accelerated aging in schizophrenia patients: the potential role of oxidative stressOlaoluwa O OkusagaMedical Hypotheses|February 5, 2014
6R-l-erythro-5,6,7,8-tetrahydrobiopterin (BH4): a potential treatment for all symptom domains of schizophreniaOlaoluwa O OkusagaThe Psychiatric Quarterly|August 29, 2014
Antipsychotic medication-induced dysphoria: its meaning, association with typical vs. atypical medications and impact on adherenceHanjing Emily Wu, Olaoluwa O OkusagaBehavioral Sciences (Basel, Switzerland)|July 2, 2021
Repetitive Transcranial Magnetic Stimulation: A Potential Treatment for Obesity in Patients with SchizophreniaRamey G Monem, Olaoluwa O OkusagaThe Psychiatric Quarterly|October 14, 2018
Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with SchizophreniaTed Boozalis, Sridevi Devaraj, Olaoluwa O OkusagaFederal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|December 30, 2022
Challenges and Considerations in Treating Negative and Cognitive Symptoms of Schizophrenia Spectrum DisordersAlison Krauss, Jared Bernard, Olaoluwa O OkusagaJournal of Addiction Medicine|February 21, 2015
Cocaine use in individuals with schizophrenia: impact on doses of discharge antipsychotic medicationsSatyajit Mohite, Ikenna Ngana, Olaoluwa O OkusagaJournal of Medicinal Food|July 25, 2009
Effect of kolaviron, a biflavonoid complex from Garcinia kola seeds, on ethanol-induced oxidative stress in liver of adult wistar ratsO A Adaramoye, I Awogbindin, J O OkusagaThe Psychiatric Quarterly|October 2, 2021
Plasma Soluble P-selectin, Interleukin-6 and S100B Protein in Patients with Schizophrenia: a Pilot StudyOmar F Pinjari, Swapan K Dasgupta, Olaoluwa O OkusagaOptics Letters|February 21, 2012
Guided entropy mode Rayleigh scattering in optical fibersO Okusaga, J Cahill, A Docherty, et al.Pageof 3